CANbridge gains its second cancer project through deal with EUSA
CANbridge Life Sciences Ltd. gained its second cancer project, licensing exclusive rights to sell in China EUSA Pharma's Caphosol oral rinse.
- Medical Devices
- Specialty Pharmaceuticals
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com